Pradžia › Šlapimo pūslės vėžys › New Jersey
Šlapimo pūslės vėžys klinikiniai tyrimai New Jersey
26 tyrimai dėl Šlapimo pūslės vėžys ieško dalyvių vietose New Jersey.
Miestai New Jersey
Oficialus tyrimo tekstas (anglų kalba)
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Hackensack University Medical Center, Hackensack
- Memorial Sloan Kettering Monmouth, Middletown
- ir dar 1
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT07000084Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Englewood Hospital and Medical Center, Englewood
- Hackettstown Medical Center, Hackettstown
- Morristown Medical Center, Morristown
- ir dar 6
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 40 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT05334069Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT06770582Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
- Jefferson Cherry Hill Hospital, Cherry Hill
- Hunterdon Medical Center, Flemington
- Jersey City Medical Center, Jersey City
- ir dar 5
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT07061964Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT03866382A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
- MSK Basking Ridge, Basking Ridge
- MSK Monmouth, Middletown
- MSK Bergen, Montvale
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07206225A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- START Astera, LLC, East Brunswick
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07277413A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
- Morristown Memorial Hospital ( Site 0795), Morristown
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07419295A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Astera Cancer Care, East Brunswick
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07218380A Study of Surgical Techniques During Cystectomy
- Memorial Sloan Kettering at Basking Ridge (Consent Only), Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent Only), Middletown
- Memorial Sloan Kettering Bergen (Consent Only), Montvale
Renkami dalyviai3 fazė
Amžius 21 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT06703476ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Astera Cancer Care, East Brunswick
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-14 · NCT05059444A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
- Rutgers Cancer Institute of New Jersey ( Site 0007), New Brunswick
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-11 · NCT07222488Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
- Rutgers Cancer Institute, New Brunswick
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-04 · NCT07144319Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
- Hackensack University Medical Center, Hackensack
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-03 · NCT06567743A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-02 · NCT05837767Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-18 · NCT07097142Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NAC)
- Rutgers Cancer Institute, New Brunswick
Renkami dalyviai2 fazė
Amžius nuo 18 iki 90 · Visoms lytims · Atnaujinta 2026-08-13 · NCT07762586LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Rutgers Cancer Institute of New Jersey, New Brunswick
- New Jersey Urology, LLC, Voorhees Township
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-07 · NCT04752722A Study of a Side Effects and Resource Navigation Program for People With Cancer
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-31 · NCT07646847A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Overlook Medical Center, Summit
Renkami dalyviai2 fazė
Amžius 8 ir vyresni · Visoms lytims · Atnaujinta 2026-07-27 · NCT05503797A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- MSK Basking Ridge, Basking Ridge
- MSK Monmouth, Middletown
- MSK Bergen, Montvale
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-22 · NCT04879329Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
- Summit Health, Voorhees Township
Renkami dalyviai
Amžius nuo 18 iki 88 · Visoms lytims · Atnaujinta 2026-07-02 · NCT06394869SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma
- Rutgers Cancer Institute, New Brunswick
Renkami dalyviai2 fazė
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-05-06 · NCT06822010A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer
- Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-22 · NCT05562791A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- Hackensack University Medical Center, Hackensack
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-13 · NCT06778863SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, New Brunswick
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2025-10-28 · NCT03452774Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.